# reAlpha Tech Corp.: financial statements, quarterly

AIRE · Nasdaq · CIK 1859199 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aire.md) · [Financials](/companies/aire/financials.md) · [Filings](/companies/aire/filings.md) · [Insiders](/companies/aire/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aire/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | Q2 FY2024 (2023-10-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.1](/filings/0001213900-24-096140.md) | [0.0](/filings/0001213900-23-096276.md) | [0.0](/filings/0001213900-25-044587.md) | [0.1](/filings/0002008589-25-000033.md) | [0.3](/filings/0001213900-25-108695.md) | [0.5 d](/filings/0001213900-26-026653.md) | [0.9](/filings/0001213900-26-048242.md) | [1.3](/filings/0001213900-26-090106.md) | [1.4](/filings/0001213900-25-108695.md) | [0.9 d](/filings/0001213900-26-026653.md) | [0.8](/filings/0001213900-26-048242.md) | [1.1](/filings/0001213900-26-090106.md) |
| Cost of revenue | $m | [0.0](/filings/0001213900-24-096140.md) | [0.0](/filings/0001213900-23-096276.md) | [0.0](/filings/0001213900-25-044587.md) | [0.0](/filings/0002008589-25-000033.md) | [0.1](/filings/0001213900-25-108695.md) | [0.2 d](/filings/0001213900-26-026653.md) | [0.4](/filings/0001213900-26-048242.md) | [0.6](/filings/0001213900-26-090106.md) | [0.7](/filings/0001213900-25-108695.md) | [0.3 d](/filings/0001213900-26-026653.md) | [0.3](/filings/0001213900-26-048242.md) | [0.4](/filings/0001213900-26-090106.md) |
| Gross profit | $m | [0.0](/filings/0001213900-24-096140.md) | [0.0](/filings/0001213900-23-096276.md) | [0.0](/filings/0001213900-25-044587.md) | [0.0](/filings/0002008589-25-000033.md) | [0.2](/filings/0001213900-25-108695.md) | [0.4 d](/filings/0001213900-26-026653.md) | [0.5](/filings/0001213900-26-048242.md) | [0.6](/filings/0001213900-26-090106.md) | [0.7](/filings/0001213900-25-108695.md) | [0.6 d](/filings/0001213900-26-026653.md) | [0.6](/filings/0001213900-26-048242.md) | [0.7](/filings/0001213900-26-090106.md) |
| Operating income | $m | [(0.7)](/filings/0001213900-24-096140.md) | [(4.2)](/filings/0001213900-23-096276.md) | [(1.3)](/filings/0001213900-25-044587.md) | [(1.2)](/filings/0002008589-25-000033.md) | [(1.6)](/filings/0001213900-25-108695.md) | [(3.0) d](/filings/0001213900-26-026653.md) | [(2.4)](/filings/0001213900-26-048242.md) | [(4.1)](/filings/0001213900-26-090106.md) | [(4.9)](/filings/0001213900-25-108695.md) | [(4.6) d](/filings/0001213900-26-026653.md) | [(4.3)](/filings/0001213900-26-048242.md) | [(2.9)](/filings/0001213900-26-090106.md) |
| Interest expense | $m | [0.0](/filings/0001213900-24-096140.md) | [0.0](/filings/0001213900-23-096276.md) | [0.0](/filings/0001213900-24-034518.md) | [0.0](/filings/0002008589-25-000033.md) | [(0.1)](/filings/0001213900-25-108695.md) | [0.2 d](/filings/0001213900-25-108695.md) | [0.2](/filings/0001213900-26-048242.md) | [0.2](/filings/0001213900-26-090106.md) | [0.0](/filings/0001213900-25-108695.md) | [0.6 d](/filings/0001213900-26-026653.md) | [0.0](/filings/0001213900-26-048242.md) | [0.0](/filings/0001213900-26-090106.md) |
| Income tax | $m | not reported | not reported | not reported | [0.0](/filings/0002008589-25-000033.md) | not reported | not reported | not reported | [0.0](/filings/0002008589-25-000033.md) | not reported | not reported | not reported | not reported |
| Net income | $m | [(0.8)](/filings/0001213900-24-096140.md) | [(4.3)](/filings/0001213900-23-096276.md) | [(1.4)](/filings/0001213900-25-044587.md) | [(1.5)](/filings/0002008589-25-000033.md) | [(2.1)](/filings/0001213900-25-108695.md) | [(21.0) d](/filings/0001213900-26-026653.md) | [(2.8)](/filings/0001213900-26-048242.md) | [(4.8)](/filings/0001213900-26-090106.md) | [(5.8)](/filings/0001213900-25-108695.md) | [(4.8) d](/filings/0001213900-26-026653.md) | [(4.3)](/filings/0001213900-26-048242.md) | [(3.0)](/filings/0001213900-26-090106.md) |
| Diluted EPS | $ per share | [(0.02)](/filings/0001213900-24-096140.md) | [(0.10)](/filings/0001213900-23-096276.md) | [(0.03)](/filings/0001213900-25-044587.md) | [(0.03)](/filings/0002008589-25-000033.md) | [(0.05)](/filings/0001213900-25-108695.md) | not reported | [(0.06)](/filings/0001213900-26-048242.md) | [(2.37)](/filings/0001213900-26-090106.md) | [(0.07)](/filings/0001213900-25-108695.md) | not reported | [(0.03)](/filings/0001213900-26-048242.md) | [(0.57)](/filings/0001213900-26-090106.md) |
| Basic EPS | $ per share | [(0.02)](/filings/0001213900-24-096140.md) | [(0.10)](/filings/0001213900-23-096276.md) | [(0.03)](/filings/0001213900-25-044587.md) | [(0.03)](/filings/0002008589-25-000033.md) | [(0.05)](/filings/0001213900-25-108695.md) | not reported | [(0.06)](/filings/0001213900-26-048242.md) | [(2.37)](/filings/0001213900-26-090106.md) | [(0.07)](/filings/0001213900-25-108695.md) | not reported | [(0.03)](/filings/0001213900-26-048242.md) | [(0.57)](/filings/0001213900-26-090106.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-10-31) | FY2024 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.6](/filings/0001213900-23-096276.md) | [6.5](/filings/0001213900-25-042783.md) | [4.8](/filings/0001213900-24-034518.md) | [3.7](/filings/0001213900-24-069180.md) | [7.1](/filings/0001213900-24-096140.md) | [3.1](/filings/0001213900-26-026653.md) | [1.2](/filings/0001213900-25-044587.md) | [0.6](/filings/0002008589-25-000033.md) | [9.3](/filings/0001213900-25-108695.md) | [7.8](/filings/0001213900-26-026653.md) | [4.7](/filings/0001213900-26-048242.md) | [2.2](/filings/0001213900-26-090106.md) |
| Current assets | $m | [2.2](/filings/0001213900-23-096276.md) | [7.4](/filings/0001213900-25-042783.md) | [5.7](/filings/0001213900-24-034518.md) | [4.5](/filings/0001213900-24-069180.md) | [8.0](/filings/0001213900-24-096140.md) | [4.0](/filings/0001213900-26-026653.md) | [6.9](/filings/0001213900-25-044587.md) | [5.1](/filings/0002008589-25-000033.md) | [12.2](/filings/0001213900-25-108695.md) | [9.8](/filings/0001213900-26-090106.md) | [5.9](/filings/0001213900-26-048242.md) | [3.5](/filings/0001213900-26-090106.md) |
| Total assets | $m | [16.5](/filings/0001213900-23-096276.md) | [27.4](/filings/0001213900-25-042783.md) | [25.4](/filings/0001213900-24-034518.md) | [24.6](/filings/0001213900-24-069180.md) | [34.2](/filings/0001213900-24-096140.md) | [12.0](/filings/0001213900-26-026653.md) | [18.5](/filings/0001213900-25-044587.md) | [15.5](/filings/0002008589-25-000033.md) | [19.7](/filings/0001213900-25-108695.md) | [21.7](/filings/0001213900-26-090106.md) | [17.6](/filings/0001213900-26-048242.md) | [15.1](/filings/0001213900-26-090106.md) |
| Current liabilities | $m | [2.5](/filings/0001213900-23-096276.md) | [2.1](/filings/0001213900-25-042783.md) | [1.1](/filings/0001213900-24-034518.md) | [1.4](/filings/0001213900-24-069180.md) | [7.7](/filings/0001213900-24-096140.md) | [4.1](/filings/0001213900-26-026653.md) | [11.8](/filings/0001213900-25-044587.md) | [9.5](/filings/0002008589-25-000033.md) | [3.1](/filings/0001213900-25-108695.md) | [3.6](/filings/0001213900-26-090106.md) | [2.7](/filings/0001213900-26-048242.md) | [3.4](/filings/0001213900-26-090106.md) |
| Total liabilities | $m | [2.7](/filings/0001213900-23-096276.md) | [2.7](/filings/0001213900-25-042783.md) | [2.1](/filings/0001213900-24-034518.md) | [2.4](/filings/0001213900-24-069180.md) | [11.6](/filings/0001213900-24-096140.md) | [10.4](/filings/0001213900-26-026653.md) | [19.5](/filings/0001213900-25-044587.md) | [16.6](/filings/0002008589-25-000033.md) | [8.8](/filings/0001213900-25-108695.md) | [9.2](/filings/0001213900-26-090106.md) | [8.3](/filings/0001213900-26-048242.md) | [8.5](/filings/0001213900-26-090106.md) |
| Long-term debt | $m | not reported | [0.2](/filings/0001213900-24-021553.md) | not reported | not reported | not reported | [0.2](/filings/0002008589-25-000033.md) | not reported | [0.2](/filings/0002008589-25-000033.md) | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [0.0](/filings/0001213900-23-096276.md) | [0.2](/filings/0001213900-24-034518.md) | [0.1](/filings/0001213900-24-034518.md) | not reported | not reported | [0.5](/filings/0002008589-25-000033.md) | not reported | [0.3](/filings/0002008589-25-000033.md) | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [13.8](/filings/0001213900-23-096276.md) | [24.7](/filings/0001213900-25-042783.md) | [23.3](/filings/0001213900-24-034518.md) | [22.2](/filings/0001213900-24-069180.md) | [22.5](/filings/0001213900-24-096140.md) | [1.6](/filings/0001213900-26-026653.md) | [(1.0)](/filings/0001213900-25-044587.md) | [(1.1)](/filings/0002008589-25-000033.md) | [10.9](/filings/0001213900-25-108695.md) | [11.5](/filings/0001213900-26-090106.md) | [8.2](/filings/0001213900-26-048242.md) | [5.6](/filings/0001213900-26-090106.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-06-30) | period not labelled (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(772) d](/filings/0001213900-24-069180.md) | [(467) d](/filings/0001213900-24-096140.md) | [(1,527)](/filings/0001213900-25-044587.md) | [(1,024) d](/filings/0002008589-25-000033.md) | [(1,255) d](/filings/0001213900-25-108695.md) | [(2,236) d](/filings/0001213900-26-026653.md) | [(2,267)](/filings/0001213900-26-048242.md) | [(2,335) d](/filings/0001213900-26-090106.md) | [(4,245) d](/filings/0001213900-25-108695.md) | [(2,415) d](/filings/0001213900-26-026653.md) | [(3,124)](/filings/0001213900-26-048242.md) | [(2,354) d](/filings/0001213900-26-090106.md) |
| Capital expenditure | $k | not reported | [29.4 d](/filings/0001213900-24-096140.md) | not reported | not reported | [7.5 d](/filings/0001213900-25-108695.md) | [3.8 d](/filings/0001213900-26-026653.md) | [13.7](/filings/0001213900-26-048242.md) | [13.4 d](/filings/0001213900-26-090106.md) | [5.5 d](/filings/0001213900-25-108695.md) | [10.3 d](/filings/0001213900-26-026653.md) | [47.3](/filings/0001213900-26-048242.md) | [10.8 d](/filings/0001213900-26-090106.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2023-03-31) | period not labelled (2023-06-30) | period not labelled (2023-09-30) | Q2 FY2024 (2023-10-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [40.8](/filings/0001213900-24-034518.md) | [42.5](/filings/0001213900-24-069180.md) | [42.5](/filings/0001213900-24-096140.md) | [42.5](/filings/0001213900-23-096276.md) | [44.1](/filings/0001213900-25-044587.md) | [44.2](/filings/0002008589-25-000033.md) | [44.4](/filings/0001213900-25-108695.md) | [45.9](/filings/0001213900-26-048242.md) | [2.1](/filings/0001213900-26-090106.md) | [81.7](/filings/0001213900-25-108695.md) | [132](/filings/0001213900-26-048242.md) | [5.4](/filings/0001213900-26-090106.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,884,275 at 2026-08-12, from the cover of the [10-Q filed 2026-08-14](/filings/0001213900-26-090106.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.